The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies

Tao Wang1 Department of Medical Oncology, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China, [email protected]

Jie Yu1 Department of Medical Oncology, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China, [email protected]

Min Liu1 Department of Medical Oncology, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China, [email protected]

Yanliang Chen1 Department of Medical Oncology, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China, [email protected]

Caiyun Zhu1 Department of Medical Oncology, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China, [email protected]

Lin Lu2 Department of Medical Oncology, Dalian Medical University, Dalian, Liaoning, China

Mingzhu Wang2 Department of Medical Oncology, Dalian Medical University, Dalian, Liaoning, China

Lingfeng Min3 Department of Respiratory Medicine, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China

Xinxin Liu4 Department of Gastrointestinal Surgery, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China

Xizhi Zhang1 Department of Medical Oncology, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China, [email protected]

Johannes A Gubat5 Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden

Yong Chen1 Department of Medical Oncology, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China, [email protected]Correspondence[email protected]

Articles from other publishers (15)